Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3

•Acute thymic involution (ATI) occurs during imiquimod-induced dermatitis.•Desmoglein 3+ thymic epithelial cells decrease in number in imiquimod-induced ATI.•Desmoglein 3-specific thymic tolerance is impaired in imiquimod-induced ATI. The thymus plays an essential role in removing autoreactive T cel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatological science 2020-12, Vol.100 (3), p.166-174
Hauptverfasser: Iriki, Hisato, Mukai, Miho, Ito, Hiromi, Kurebayashi, Yutaka, Amagai, Masayuki, Takahashi, Hayato
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 174
container_issue 3
container_start_page 166
container_title Journal of dermatological science
container_volume 100
creator Iriki, Hisato
Mukai, Miho
Ito, Hiromi
Kurebayashi, Yutaka
Amagai, Masayuki
Takahashi, Hayato
description •Acute thymic involution (ATI) occurs during imiquimod-induced dermatitis.•Desmoglein 3+ thymic epithelial cells decrease in number in imiquimod-induced ATI.•Desmoglein 3-specific thymic tolerance is impaired in imiquimod-induced ATI. The thymus plays an essential role in removing autoreactive T cells. Autoantigen-expressing thymic epithelial cells (TECs) contribute to the tolerogenic process. The thymus transiently shrinks as an acute thymic involution (ATI) under various inflammatory conditions. However, whether ATI occurs during local skin inflammation remains unclear, as does its influence on thymic immune tolerance. We investigated whether imiquimod-induced dermatitis causes ATI and impairs thymic immune tolerance against desmoglein 3 (Dsg3), an epidermal autoantigen of pemphigus vulgaris. 5% imiquimod cream was applied daily, at 62.5 mg/day (high dose group) or 31.25 mg/day (low dose group), for 1 week on the back of wild-type mice, and to wild-type mice that had undergone bone-marrow transplantation from Dsg3-specific T-cell receptor (TCR) transgenic-Rag2−/− mice. Next, thymocytes, TECs and other immune cells were analyzed by flow cytometry. TEC-associated Dsg3 expression was also analyzed by immunofluorescence staining. Thymus weight and thymocyte number in all developmental stages decreased in a dose-dependent manner under imiquimod-induced dermatitis. The number of total TECs, specifically medullary, but not cortical, TECs, decreased in high and low dose groups. Accordingly, the number of Dsg3-experssing UEA-1+keratin 5+mTEC decreased in the thymus during imiquimod-induced dermatitis. Although Dsg3-sepcific transgenic thymocytes was usually deleted in the thymus under physiological condition by central tolerance, Dsg3-sepcific transgenic CD4+CD8− thymocytes significantly increased in number under imiquimod-induced dermatitis. These findings indicate a crosstalk between skin and thymus in adult mice and suggest that skin inflammation may impair thymic tolerance to autoantigens, such as Dsg3.
doi_str_mv 10.1016/j.jdermsci.2020.09.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2449181042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923181120302966</els_id><sourcerecordid>2449181042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-e0904018779d01dadc6316015988660d0f6ce21245da5962039e2f3f95d6630d3</originalsourceid><addsrcrecordid>eNqFkMFOGzEQhq2qqAToKyAfkardju1dZ30DBVqQkHoBiZtl7NniaB0H2xuJt8dRoNee5vLN_898hJwzaBkw-XPdrh2mkK1vOXBoQbUAyy9kwYalaHqpnr6SBSguGjYwdkxOcl4DQM879Y0cCwFcLIduQZ7vgn-dfYiu8Rs3W3R0n2uKLz5TH7bGp0zLy1vwlpY4YTIbizSO1MwlJjS2-B3S1XX3gz5Qi9NU6Vgzcoh_J_QbKs7I0WimjN8_5il5_HXzsLpt7v_8vltd3TdWKF4aBAUd1POXygFzxlkpmATWq2GQEhyM0iJnvOud6ZXkIBTyUYyqd1IKcOKUXBxytym-zpiLDj7vLzIbjHPWvOtUlQEdr6g8oDbFnBOOept8MOlNM9B7v3qtP_3qvV8NSle_dfH8o2N-Duj-rX0KrcDlAcD66c5j0jUCqzLnE9qiXfT_63gH9xWOrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2449181042</pqid></control><display><type>article</type><title>Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3</title><source>Elsevier ScienceDirect Journals</source><creator>Iriki, Hisato ; Mukai, Miho ; Ito, Hiromi ; Kurebayashi, Yutaka ; Amagai, Masayuki ; Takahashi, Hayato</creator><creatorcontrib>Iriki, Hisato ; Mukai, Miho ; Ito, Hiromi ; Kurebayashi, Yutaka ; Amagai, Masayuki ; Takahashi, Hayato</creatorcontrib><description>•Acute thymic involution (ATI) occurs during imiquimod-induced dermatitis.•Desmoglein 3+ thymic epithelial cells decrease in number in imiquimod-induced ATI.•Desmoglein 3-specific thymic tolerance is impaired in imiquimod-induced ATI. The thymus plays an essential role in removing autoreactive T cells. Autoantigen-expressing thymic epithelial cells (TECs) contribute to the tolerogenic process. The thymus transiently shrinks as an acute thymic involution (ATI) under various inflammatory conditions. However, whether ATI occurs during local skin inflammation remains unclear, as does its influence on thymic immune tolerance. We investigated whether imiquimod-induced dermatitis causes ATI and impairs thymic immune tolerance against desmoglein 3 (Dsg3), an epidermal autoantigen of pemphigus vulgaris. 5% imiquimod cream was applied daily, at 62.5 mg/day (high dose group) or 31.25 mg/day (low dose group), for 1 week on the back of wild-type mice, and to wild-type mice that had undergone bone-marrow transplantation from Dsg3-specific T-cell receptor (TCR) transgenic-Rag2−/− mice. Next, thymocytes, TECs and other immune cells were analyzed by flow cytometry. TEC-associated Dsg3 expression was also analyzed by immunofluorescence staining. Thymus weight and thymocyte number in all developmental stages decreased in a dose-dependent manner under imiquimod-induced dermatitis. The number of total TECs, specifically medullary, but not cortical, TECs, decreased in high and low dose groups. Accordingly, the number of Dsg3-experssing UEA-1+keratin 5+mTEC decreased in the thymus during imiquimod-induced dermatitis. Although Dsg3-sepcific transgenic thymocytes was usually deleted in the thymus under physiological condition by central tolerance, Dsg3-sepcific transgenic CD4+CD8− thymocytes significantly increased in number under imiquimod-induced dermatitis. These findings indicate a crosstalk between skin and thymus in adult mice and suggest that skin inflammation may impair thymic tolerance to autoantigens, such as Dsg3.</description><identifier>ISSN: 0923-1811</identifier><identifier>EISSN: 1873-569X</identifier><identifier>DOI: 10.1016/j.jdermsci.2020.09.007</identifier><identifier>PMID: 33023784</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute thymic involution ; Autoimmunity ; Central tolerance ; Cortical thymic epithelial cells ; Desmoglein 3 ; Imiquimod ; Immunological tolerance ; Medullary thymic epitherial cells ; Negetive selection ; Pemphigus vulgaris ; Thymic epitherial cells ; Thymic tolerance ; Toll like receptor 7 ; Toll like receptor 9</subject><ispartof>Journal of dermatological science, 2020-12, Vol.100 (3), p.166-174</ispartof><rights>2020 Japanese Society for Investigative Dermatology</rights><rights>Copyright © 2020 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-e0904018779d01dadc6316015988660d0f6ce21245da5962039e2f3f95d6630d3</citedby><cites>FETCH-LOGICAL-c392t-e0904018779d01dadc6316015988660d0f6ce21245da5962039e2f3f95d6630d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jdermsci.2020.09.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33023784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iriki, Hisato</creatorcontrib><creatorcontrib>Mukai, Miho</creatorcontrib><creatorcontrib>Ito, Hiromi</creatorcontrib><creatorcontrib>Kurebayashi, Yutaka</creatorcontrib><creatorcontrib>Amagai, Masayuki</creatorcontrib><creatorcontrib>Takahashi, Hayato</creatorcontrib><title>Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3</title><title>Journal of dermatological science</title><addtitle>J Dermatol Sci</addtitle><description>•Acute thymic involution (ATI) occurs during imiquimod-induced dermatitis.•Desmoglein 3+ thymic epithelial cells decrease in number in imiquimod-induced ATI.•Desmoglein 3-specific thymic tolerance is impaired in imiquimod-induced ATI. The thymus plays an essential role in removing autoreactive T cells. Autoantigen-expressing thymic epithelial cells (TECs) contribute to the tolerogenic process. The thymus transiently shrinks as an acute thymic involution (ATI) under various inflammatory conditions. However, whether ATI occurs during local skin inflammation remains unclear, as does its influence on thymic immune tolerance. We investigated whether imiquimod-induced dermatitis causes ATI and impairs thymic immune tolerance against desmoglein 3 (Dsg3), an epidermal autoantigen of pemphigus vulgaris. 5% imiquimod cream was applied daily, at 62.5 mg/day (high dose group) or 31.25 mg/day (low dose group), for 1 week on the back of wild-type mice, and to wild-type mice that had undergone bone-marrow transplantation from Dsg3-specific T-cell receptor (TCR) transgenic-Rag2−/− mice. Next, thymocytes, TECs and other immune cells were analyzed by flow cytometry. TEC-associated Dsg3 expression was also analyzed by immunofluorescence staining. Thymus weight and thymocyte number in all developmental stages decreased in a dose-dependent manner under imiquimod-induced dermatitis. The number of total TECs, specifically medullary, but not cortical, TECs, decreased in high and low dose groups. Accordingly, the number of Dsg3-experssing UEA-1+keratin 5+mTEC decreased in the thymus during imiquimod-induced dermatitis. Although Dsg3-sepcific transgenic thymocytes was usually deleted in the thymus under physiological condition by central tolerance, Dsg3-sepcific transgenic CD4+CD8− thymocytes significantly increased in number under imiquimod-induced dermatitis. These findings indicate a crosstalk between skin and thymus in adult mice and suggest that skin inflammation may impair thymic tolerance to autoantigens, such as Dsg3.</description><subject>Acute thymic involution</subject><subject>Autoimmunity</subject><subject>Central tolerance</subject><subject>Cortical thymic epithelial cells</subject><subject>Desmoglein 3</subject><subject>Imiquimod</subject><subject>Immunological tolerance</subject><subject>Medullary thymic epitherial cells</subject><subject>Negetive selection</subject><subject>Pemphigus vulgaris</subject><subject>Thymic epitherial cells</subject><subject>Thymic tolerance</subject><subject>Toll like receptor 7</subject><subject>Toll like receptor 9</subject><issn>0923-1811</issn><issn>1873-569X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkMFOGzEQhq2qqAToKyAfkardju1dZ30DBVqQkHoBiZtl7NniaB0H2xuJt8dRoNee5vLN_898hJwzaBkw-XPdrh2mkK1vOXBoQbUAyy9kwYalaHqpnr6SBSguGjYwdkxOcl4DQM879Y0cCwFcLIduQZ7vgn-dfYiu8Rs3W3R0n2uKLz5TH7bGp0zLy1vwlpY4YTIbizSO1MwlJjS2-B3S1XX3gz5Qi9NU6Vgzcoh_J_QbKs7I0WimjN8_5il5_HXzsLpt7v_8vltd3TdWKF4aBAUd1POXygFzxlkpmATWq2GQEhyM0iJnvOud6ZXkIBTyUYyqd1IKcOKUXBxytym-zpiLDj7vLzIbjHPWvOtUlQEdr6g8oDbFnBOOept8MOlNM9B7v3qtP_3qvV8NSle_dfH8o2N-Duj-rX0KrcDlAcD66c5j0jUCqzLnE9qiXfT_63gH9xWOrg</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Iriki, Hisato</creator><creator>Mukai, Miho</creator><creator>Ito, Hiromi</creator><creator>Kurebayashi, Yutaka</creator><creator>Amagai, Masayuki</creator><creator>Takahashi, Hayato</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202012</creationdate><title>Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3</title><author>Iriki, Hisato ; Mukai, Miho ; Ito, Hiromi ; Kurebayashi, Yutaka ; Amagai, Masayuki ; Takahashi, Hayato</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-e0904018779d01dadc6316015988660d0f6ce21245da5962039e2f3f95d6630d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acute thymic involution</topic><topic>Autoimmunity</topic><topic>Central tolerance</topic><topic>Cortical thymic epithelial cells</topic><topic>Desmoglein 3</topic><topic>Imiquimod</topic><topic>Immunological tolerance</topic><topic>Medullary thymic epitherial cells</topic><topic>Negetive selection</topic><topic>Pemphigus vulgaris</topic><topic>Thymic epitherial cells</topic><topic>Thymic tolerance</topic><topic>Toll like receptor 7</topic><topic>Toll like receptor 9</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iriki, Hisato</creatorcontrib><creatorcontrib>Mukai, Miho</creatorcontrib><creatorcontrib>Ito, Hiromi</creatorcontrib><creatorcontrib>Kurebayashi, Yutaka</creatorcontrib><creatorcontrib>Amagai, Masayuki</creatorcontrib><creatorcontrib>Takahashi, Hayato</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatological science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iriki, Hisato</au><au>Mukai, Miho</au><au>Ito, Hiromi</au><au>Kurebayashi, Yutaka</au><au>Amagai, Masayuki</au><au>Takahashi, Hayato</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3</atitle><jtitle>Journal of dermatological science</jtitle><addtitle>J Dermatol Sci</addtitle><date>2020-12</date><risdate>2020</risdate><volume>100</volume><issue>3</issue><spage>166</spage><epage>174</epage><pages>166-174</pages><issn>0923-1811</issn><eissn>1873-569X</eissn><abstract>•Acute thymic involution (ATI) occurs during imiquimod-induced dermatitis.•Desmoglein 3+ thymic epithelial cells decrease in number in imiquimod-induced ATI.•Desmoglein 3-specific thymic tolerance is impaired in imiquimod-induced ATI. The thymus plays an essential role in removing autoreactive T cells. Autoantigen-expressing thymic epithelial cells (TECs) contribute to the tolerogenic process. The thymus transiently shrinks as an acute thymic involution (ATI) under various inflammatory conditions. However, whether ATI occurs during local skin inflammation remains unclear, as does its influence on thymic immune tolerance. We investigated whether imiquimod-induced dermatitis causes ATI and impairs thymic immune tolerance against desmoglein 3 (Dsg3), an epidermal autoantigen of pemphigus vulgaris. 5% imiquimod cream was applied daily, at 62.5 mg/day (high dose group) or 31.25 mg/day (low dose group), for 1 week on the back of wild-type mice, and to wild-type mice that had undergone bone-marrow transplantation from Dsg3-specific T-cell receptor (TCR) transgenic-Rag2−/− mice. Next, thymocytes, TECs and other immune cells were analyzed by flow cytometry. TEC-associated Dsg3 expression was also analyzed by immunofluorescence staining. Thymus weight and thymocyte number in all developmental stages decreased in a dose-dependent manner under imiquimod-induced dermatitis. The number of total TECs, specifically medullary, but not cortical, TECs, decreased in high and low dose groups. Accordingly, the number of Dsg3-experssing UEA-1+keratin 5+mTEC decreased in the thymus during imiquimod-induced dermatitis. Although Dsg3-sepcific transgenic thymocytes was usually deleted in the thymus under physiological condition by central tolerance, Dsg3-sepcific transgenic CD4+CD8− thymocytes significantly increased in number under imiquimod-induced dermatitis. These findings indicate a crosstalk between skin and thymus in adult mice and suggest that skin inflammation may impair thymic tolerance to autoantigens, such as Dsg3.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33023784</pmid><doi>10.1016/j.jdermsci.2020.09.007</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0923-1811
ispartof Journal of dermatological science, 2020-12, Vol.100 (3), p.166-174
issn 0923-1811
1873-569X
language eng
recordid cdi_proquest_miscellaneous_2449181042
source Elsevier ScienceDirect Journals
subjects Acute thymic involution
Autoimmunity
Central tolerance
Cortical thymic epithelial cells
Desmoglein 3
Imiquimod
Immunological tolerance
Medullary thymic epitherial cells
Negetive selection
Pemphigus vulgaris
Thymic epitherial cells
Thymic tolerance
Toll like receptor 7
Toll like receptor 9
title Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4+ T cells to desmoglein 3
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A15%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imiquimod-induced%20dermatitis%20impairs%20thymic%20tolerance%20of%20autoreactive%20CD4+%20T%20cells%20to%20desmoglein%203&rft.jtitle=Journal%20of%20dermatological%20science&rft.au=Iriki,%20Hisato&rft.date=2020-12&rft.volume=100&rft.issue=3&rft.spage=166&rft.epage=174&rft.pages=166-174&rft.issn=0923-1811&rft.eissn=1873-569X&rft_id=info:doi/10.1016/j.jdermsci.2020.09.007&rft_dat=%3Cproquest_cross%3E2449181042%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2449181042&rft_id=info:pmid/33023784&rft_els_id=S0923181120302966&rfr_iscdi=true